-
Lenalidomide, sold
under the
brand name
Revlimid among others, is a
medication used to
treat multiple myeloma,
smoldering myeloma, and myelodysplastic...
- 83% at 30 months,
lenalidomide plus low-dose
dexamethasone an 82%
survival at 2 years, and melphalan, prednisone, and
lenalidomide had a 90% survival...
-
blood cells, and antibiotics. Drug
therapy may
include the
medications lenalidomide,
antithymocyte globulin, and azacitidine. Some
people can be
cured by...
- that
makes cancer and
immunology drugs. Its
major product is
Revlimid (
lenalidomide),
which is used in the
treatment of
multiple myeloma, and also in certain...
-
There may be
accompanying erythroid hypoplasia in the bone marrow.
Lenalidomide has
activity in 5q-
syndrome and is FDA
approved for red
blood cell (RBC)...
-
imide group. The IMiD
class includes thalidomide and its
analogues (
lenalidomide, pomalidomide,
mezigdomide and iberdomide).
These drugs may also be referred...
-
humanized IgG1
monoclonal antibody medication used in
combination with
lenalidomide and dexamethasone, for
adults that have
received 1 to 3
prior therapies...
-
Lenalidomide or
lenalidomide plus
dexamethasone (Rd) is a
common treatment for high risk SMM. Many
clinical trials have
shown that a
lenalidomide based...
-
including treatment with
bortezomib and an
immunomodulatory therapy (such as
lenalidomide) and have
demonstrated disease progression on or
within 60 days of completion...
-
under the
brand name Monjuvi, is a
medication used in
combination with
lenalidomide for the
treatment of
adults with
relapsed or
refractory diffuse large...
